• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ALKBH5介导的XBP1的m⁶A修饰通过IL-6-JAK-STAT3途径促进非小细胞肺癌进展。

ALKBH5-Mediated mA Modification of XBP1 Facilitates NSCLC Progression Through the IL-6-JAK-STAT3 Pathway.

作者信息

Liang Hengxing, Zhang Chunmin, Hu Minxin, Hu Fang, Wang Saihui, Wei Wei, Hu Wen

机构信息

Department of Thoracic Surgery, Guilin Hospital of the Second Xiangya Hospital CSU, Guilin, China.

Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, China.

出版信息

Mol Carcinog. 2025 Jan;64(1):57-71. doi: 10.1002/mc.23826. Epub 2024 Oct 10.

DOI:10.1002/mc.23826
PMID:39387829
Abstract

The X-box-binding protein 1 (XBP1) is an important transcription factor during endoplasmic reticulum stress response, which was reported as an oncogene in non-small cell lung cancer (NSCLC) tumorigenesis and development. However, the regulatory mechanism of XBP1 expression in NSCLC progression was less reported. N6-methyladenosine (mA) RNA modification is an emerging epigenetic regulatory mechanism for gene expression. This study aimed to investigate the regulatory role of the mA modification in XBP1 expression in NSCLC. We identified XBP1 as a downstream target of ALKBH5-mediated mA modification in A549 and PC9 cells. Knockdown of ALKBH5 increased the mA modification and the stability of XBP1 mRNA, while overexpression of ALKBH5 had the opposite effect. Furthermore, IGF2BP3 was confirmed to be a reader of XBP1 mA methylation and to enhance the stability of XBP1 mRNA. Additionally, IGF2BP3 knockdown significantly reversed the increase in XBP1 stability mediated by ALKBH5 depletion. In vivo and in vitro experiments demonstrated that ALKBH5/IGF2BP3 promotes the proliferation, migration, and invasion of NSCLC cells by upregulating XBP1 expression. In addition, we also showed that XBP1 promoted NSCLC cell proliferation, migration, and invasion by activating IL-6-JAK-STAT3 signaling. Our research suggested that ALKBH5-mediated mA modification of XBP1 facilitates NSCLC progression through the IL-6-JAK-STAT3 pathway.

摘要

X盒结合蛋白1(XBP1)是内质网应激反应过程中的一种重要转录因子,据报道其在非小细胞肺癌(NSCLC)的肿瘤发生和发展中作为癌基因发挥作用。然而,XBP1表达在NSCLC进展中的调控机制报道较少。N6-甲基腺苷(m⁶A)RNA修饰是一种新兴的基因表达表观遗传调控机制。本研究旨在探讨m⁶A修饰在NSCLC中对XBP1表达的调控作用。我们确定XBP1是A549和PC9细胞中ALKBH5介导的m⁶A修饰的下游靶点。敲低ALKBH5会增加XBP1 mRNA的m⁶A修饰和稳定性,而过表达ALKBH5则产生相反的效果。此外,IGF2BP3被证实是XBP1 m⁶A甲基化的读取蛋白,并能增强XBP1 mRNA的稳定性。另外,敲低IGF2BP3可显著逆转由ALKBH5缺失介导的XBP1稳定性增加。体内和体外实验表明,ALKBH5/IGF2BP3通过上调XBP1表达促进NSCLC细胞的增殖、迁移和侵袭。此外,我们还表明XBP1通过激活IL-6-JAK-STAT3信号通路促进NSCLC细胞的增殖、迁移和侵袭。我们的研究表明,ALKBH5介导的XBP1的m⁶A修饰通过IL-6-JAK-STAT3途径促进NSCLC进展。

相似文献

1
ALKBH5-Mediated mA Modification of XBP1 Facilitates NSCLC Progression Through the IL-6-JAK-STAT3 Pathway.ALKBH5介导的XBP1的m⁶A修饰通过IL-6-JAK-STAT3途径促进非小细胞肺癌进展。
Mol Carcinog. 2025 Jan;64(1):57-71. doi: 10.1002/mc.23826. Epub 2024 Oct 10.
2
N-methyladenosine ALKBH5 promotes non-small cell lung cancer progress by regulating TIMP3 stability.N6-甲基腺苷 ALKBH5 通过调控 TIMP3 稳定性促进非小细胞肺癌进展。
Gene. 2020 Mar 20;731:144348. doi: 10.1016/j.gene.2020.144348. Epub 2020 Jan 9.
3
High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.高表达 AlkB 同源物 5 通过促进 SLC7A11 的 m6A 去甲基化来促进铁死亡,从而抑制非小细胞肺癌的进展。
Environ Toxicol. 2024 Jul;39(7):4035-4046. doi: 10.1002/tox.24272. Epub 2024 Apr 20.
4
ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages.ALKBH5 通过调节肿瘤与巨噬细胞之间的相互作用促进非小细胞肺癌的进展和对抗 PD-L1 治疗的敏感性。
J Exp Clin Cancer Res. 2024 Jun 14;43(1):164. doi: 10.1186/s13046-024-03073-0.
5
mA demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC.mA 去甲基化酶 ALKBH5 通过降低 YTHDF 介导的 YAP 表达以及抑制 miR-107/LATS2 介导的 YAP 活性来抑制非小细胞肺癌的肿瘤生长和转移。
Mol Cancer. 2020 Feb 27;19(1):40. doi: 10.1186/s12943-020-01161-1.
6
ALKBH5 Inhibits YTHDF2-m6A-Mediated Degradation of RCN1 mRNA to Promote Keloid Formation by Activating IRE1α-XBP1-Mediated ER Stress.ALKBH5通过激活IRE1α-XBP1介导的内质网应激抑制YTHDF2-m6A介导的RCN1 mRNA降解,从而促进瘢痕疙瘩形成。
J Cosmet Dermatol. 2025 Apr;24(4):e70177. doi: 10.1111/jocd.70177.
7
RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.RNA 去甲基酶 ALKBH5 通过调节非小细胞肺癌中的 TGF-β/SMAD 信号通路抑制 TGF-β 诱导的 EMT。
FASEB J. 2022 May;36(5):e22283. doi: 10.1096/fj.202200005RR.
8
Silencing of inhibits tumour progression and glycolysis by inactivating the IL‑6/JAK/STAT3 pathway in non‑small cell lung cancer.沉默通过失活 IL-6/JAK/STAT3 通路抑制非小细胞肺癌中的肿瘤进展和糖酵解。
Int J Mol Med. 2021 Dec;48(6). doi: 10.3892/ijmm.2021.5055. Epub 2021 Oct 29.
9
ALKBH5 facilitates tumor progression via an m6A-YTHDC1-dependent mechanism in glioma.在胶质瘤中,ALKBH5通过一种m6A - YTHDC1依赖性机制促进肿瘤进展。
Cancer Lett. 2025 Mar 1;612:217439. doi: 10.1016/j.canlet.2025.217439. Epub 2025 Jan 4.
10
KRAS mutants confer platinum resistance by regulating ALKBH5 posttranslational modifications in lung cancer.KRAS突变体通过调节肺癌中ALKBH5的翻译后修饰赋予铂耐药性。
J Clin Invest. 2025 Feb 4;135(6):e185149. doi: 10.1172/JCI185149.

引用本文的文献

1
M6A Demethylase ALKBH5 in Human Diseases: From Structure to Mechanisms.人类疾病中的m6A去甲基化酶ALKBH5:从结构到机制
Biomolecules. 2025 Jan 21;15(2):157. doi: 10.3390/biom15020157.
2
METTL14-mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination.METTL14介导的ZFP14的m6A修饰通过促进STAT3泛素化抑制肾透明细胞癌进展。
Clin Transl Med. 2025 Feb;15(2):e70232. doi: 10.1002/ctm2.70232.